Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
Open Access
- 1 January 2014
- journal article
- review article
- Published by Springer Nature in Molecular Cancer
- Vol. 13 (1) , 262
Abstract
Despite decades of research, ovarian cancer is still associated with unacceptably high mortality rates, which must be addressed by novel therapeutic approaches. One avenue through which this may be achieved is targeting of tumor-initiating ‘Cancer Stem Cells’ (CSCs). CSCs are sufficient to generate primary and recurrent disease through extensive rounds of asymmetric division, which maintain the CSC pool while producing the tissues that form the bulk of the tumor. CSCs thrive in the harsh tumor niche, are generally refractory to therapeutic intervention and closely-linked to the Epithelial-Mesenchymal Transition process, which facilitates invasion and metastasis. While it is well-accepted that CSC-targeting must be assessed as a novel therapeutic avenue, few ovarian CSC models have been developed due to perceived and actual difficulties associated with the process of ‘CSC Discovery’. In this article we review contemporary approaches to CSC Discovery and argue that this process should start with an understanding of the specific challenges associated with clinical intervention, laying the pipeline backwards towards CSC Discovery. Such an approach would expedite the bridging of the gap between laboratory isolation and clinical targeting of ovarian CSCs.Keywords
This publication has 107 references indexed in Scilit:
- Understanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacologica Sinica, 2013
- Low MAD2 expression levels associate with reduced progression‐free survival in patients with high‐grade serous epithelial ovarian cancerThe Journal of Pathology, 2011
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cellsInternational Journal of Cancer, 2011
- Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell lineCellular and Molecular Life Sciences, 2010
- Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapyCancer and Metastasis Reviews, 2010
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like CellsCell Stem Cell, 2009
- Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targetsExperimental Cell Research, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007